The home infusion therapy devices market size is projected to be valued at US$ 2.3 Billion in 2023 and is expected to rise to US$ 4.4 Billion by 2033. The sales of home infusion therapy devices are expected to grow at a significant CAGR of 6.6% during the forecast period. Various factors propelling the demand for home infusion therapy devices are:
The usefulness of home infusion therapy devices in modern times cannot be overstated because the medical community has evolved with various new treatment lines.
Due to improvements in medical practices and procedures, there has been an increase in demand for home infusion therapy devices globally. Market expansion has been aided by the seamless medical industry's commitment to developing innovative technology.
The availability of qualified medical professionals who are acquainted with the newest medical technologies has also fueled industry expansion. It is natural to anticipate that the availability of infusion therapy equipment will promote the expansion of related medical fraternities.
In the coming years, the global home infusion therapy devices market is expected to draw the attention of key investing entities. Furthermore, the popularity of home infusion treatments has prompted infusion therapy device makers to accelerate their manufacturing process.
The presence of multiple players in the global home infusion therapy devices market is also an important market growth dynamic. Across the infusion therapy devices market, there has been a trend of inter-competitor support. This trend has had a direct impact on the global home infusion therapy devices market's growth dynamics.
Several diseases, including immunological deficiencies, cancer, and congestive heart failure, can only be treated with infusion therapy rather than oral medication. Home infusion therapy is thought to be more economical than inpatient treatment for these individuals as they need long-term care.
| Attribute | Details |
|---|---|
| Home Infusion Therapy Devices Market Estimated Size (2023) | US$ 2.3 Billion |
| Home Infusion Therapy Devices Market CAGR (2023 to 2033) | 6.6% |
| Home Infusion Therapy Devices Market Forecasted Size (2033) | US$ 4.4 Billion |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The global home infusion therapy devices market expanded at over 5.3% CAGR in 2021. Driven by the increasing sensitivity of people towards orally administered medicines and the rising prevalence of GI-related disorders, the market is poised to expand at 6.6% CAGR through 2033.
As patients now prefer shorter stays in hospitals and due to the outbreak of COVID-19, the demand for home infusion therapy has considerably increased. Slow administration of drugs, and antibiotics in hospitals, and the risk of getting an infection are the major reasons for the improved adoption of home infusion therapy devices.
It is also considered a preferred choice for the treatment of cancer and GI-related diseases or any medical condition when orally administered medicines are not working. Approximately, 33% of cancer survivors have chronic pain and need infusion therapy and direct administration of drugs for rapid relief.
Due to the increasing preference among patients and the high prevalence of cancer across the globe, the home infusion therapy devices market is expected to grow rapidly during the forecast period.
The market is expected to observe an incremental $ opportunity of more than US$ 2.1 Billion through 2023 & beyond.
The rising acceptance of specialty infusion therapy presents strong growth opportunities for manufacturers. It is a specific type of infusion therapy that involves the administration of medication using specialty medical infusion pumps, designed to accommodate a particular type of fluid or medication.
Among all the product types, insulin pumps are expected to show the maximum growth, exhibiting growth at a CAGR of 8.2% from 2021 to 2031. The rising prevalence of diabetes across the globe is improving the demand for insulin pumps.
According to the National Health Service (NHS) United Kingdom, the incidence of diabetes has increased by approximately 60% over the past decade.
Rising cases of chronic diseases such as diabetes and cancer are improving the adoption of these devices. This will in turn create attractive opportunities for home infusion therapy device manufacturers.
Mergers and acquisitions are expanding home infusion therapy devices' global reach
Baxter International also finalized the purchase of Hillrom in December 2021. The company will benefit from this acquisition by expanding its geographic reach and incorporating medical device technologies that will improve patient care, reduce costs, and boost workflow efficiency. Additionally, in March 2021, Terumo and Glooko, a provider of mobile apps and remote patient monitoring software, announced technological cooperation to deliver fresh diabetes data solutions internationally. Data from Terumo's diabetes management devices will be able to be integrated into Glooko's diabetic data management platform via the agreement. The Australian Therapeutic Goods Administration granted CE marking and marketing authorization for the Evo IQ Syringe Infusion System in May 2020, according to a statement from Baxter International. Such acquisitions and mergers would proliferate and expand market reach globally.
Principal Consultant
The market for home infusion therapy is predicted to be dominated by infusion system accessories. By the end of the analysis period, it is anticipated to grow at a 5.8% CAGR and reach USD 18.2 billion. Infusion system accessories offer a number of advantages, including the capacity to administer fluids in minuscule amounts and at precisely timed intervals. They can be used to provide nutrition or medications including antibiotics, chemotherapeutic treatments, hormones like insulin, and painkillers. There are several different kinds of infusion pumps available, including large volume, patient-controlled analgesia (PCA), elastomeric, syringe, enteral, and insulin pumps.
The growing cases of malnutrition around the world are rising the need for enteral feeding nutrition. Furthermore, enteral nutrition is cost-effective and simpler in comparison to other alternatives. Enteral feeding maintains GI mucosal barrier and prevents muscle catabolism. Enteral nutrition is highly preferred in-home medical setup due to fewer complications and its efficient use of nutrients.
The main drivers of the market's growth are the rising incidence of chronic diseases and the mounting strain on the infrastructure of primary healthcare. In this region, it's typical to have neurological illnesses, rheumatoid arthritis, hemophilia, immune system deficits, and multiple sclerosis. The number of patients served by home infusion and specialized providers in the United States in 2019 was over 3 million, increasing 300 percent from the previous industry research in 2008. By 2020, home and specialty infusion will generate $19 billion in revenue, with 3.2 million patients being served by more than 900 clinicians. This figure is anticipated to increase over the anticipated timeframe, supporting the market growth for home infusion therapy.
| US Market Size (US$Mn/Bn) by End of Forecast Period (2033) | US$ 1.7 Billion |
|---|---|
| US Market Absolute Dollar Growth (US$ Million/Billion) | US$ 869.6 Million |
| CAGR % 2017 to 2022 | 6.6% |
| CAGR % 2023 to End of Forecast (2033) | 7.0% |
Traditional patient care patterns are changing throughout the United Kingdom as a result of advancements in demography, epidemiology, socioeconomics, and culture. A result of shifting demographics is an increase in the popularity of home infusion therapy. The population makeup of European Union (EU) nations will drastically change soon. It is anticipated that the percentage of elderly and very elderly people would rise. By 2025, the largest age group will be made up of adults between the ages of 40 and 44, predicts Statista (52.7 million). The market for home infusion therapy in this area is expanding mostly due to the growing elderly population.
| UK Market Size (US$Million/Billion) by End of Forecast Period (2033) | US$ 274.8 Million |
|---|---|
| UK Market Absolute Dollar Growth (US$ Million/Billion) | US$ 146.0 Million |
| CAGR % 2017 to 2022 | 7.0% |
| CAGR % 2023 to End of Forecast (2033) | 7.9% |
Due to the region's dense population, the Asia-Pacific region is expected to experience the greatest CAGR growth in the home infusion treatment market. Countries with dense populations include China, India, Japan, and South Korea.
Hospitals are encouraging the use of home infusion therapy for patients who can be treated at home in order to lessen the burden on primary healthcare facilities. In this area, chronic illnesses like rheumatoid arthritis, cancer, mental illnesses, and cardiovascular conditions are widespread. The early stages of these illnesses can be managed at home with the help of a healthcare expert. The market is anticipated to expand because of the rising prevalence of chronic diseases and increased public awareness of the advantages of home infusion therapy.
| China Market Size (US$Million/Billion) by End of Forecast Period (2033) | US$ 355.7 Million |
|---|---|
| China Market Absolute Dollar Growth (US$ Million/Billion) | US$ 192.0 Million |
| CAGR % 2017 to 2022 | 6.8% |
| CAGR % 2023 to End of Forecast (2033) | 8.1% |
Japan currently owns a market share of over 38% in East Asia, and in 2021, it is expected to grow at a CAGR of 7.0%. Since Japan's healthcare sector is experiencing an increase in technical growth, major firms are keeping an eye on the country.
To diversify their product offerings and clientele, leading firms in Japan are partnering with and buying regional healthcare manufacturers. The market for home infusion therapy devices will consequently be driven by this.
For instance, Terumo Corporation announced in February 2021 that it had reached a deal to purchase Health Outcomes Sciences, Inc. This agreement expands Terumo's footprint in the digital healthcare sector and provides a huge prospect for future growth.
| Japan Market Size (US$Million/Billion) by End of Forecast Period (2033) | US$ 227.5 Million |
|---|---|
| Japan Market Absolute Dollar Growth (US$ Million/Billion) | US$ 111.9 Million |
| CAGR % 2017 to 2022 | 5.6% |
| CAGR % 2023 to End of Forecast (2033) | 7.0% |
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
High levels of competition have been seen in the international market. The quick uptake of cutting-edge medical technology for better healthcare services is one of the main causes of boosting competition among industry participants. Moreover, large players frequently employ tactics like mergers, acquisitions, and new product releases in order to maintain market share and broaden their product portfolio.
Latest Developments
| Attribute | Details |
|---|---|
| Growth Rate | CAGR of 6.6% from 2023 to 2033 |
| Base Year of Estimation | 2022 |
| Historical Data | 2018 to 2022 |
| Forecast Period | 2023 to 2033 |
| Quantitative Units | Revenue in US$ Million and Volume in Units and F-CAGR from 2022 to 2032 |
| Report Coverage | Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, growth factors, Trends, and Pricing Analysis |
| Key Segments Covered | By Product, By Application, By End User, By Region |
| Regions Covered | North America; Latin America; Europe; East Asia; South Asia; Middle East & Africa; Oceania |
| Key Countries Profiled | USA, Canada, Brazil, Mexico, Germany, Italy, France, United Kingdom, Spain, Russia, China, Japan, India, GCC Countries, Australia |
| Key Companies Profiled | CVS/Coram; Option Care Health; CareFusion Corporation; BriovaRx/Diplomat (UnitedHealth Optum); PharMerica; Fresenius Kabi; CU Medical, Inc.; B. Braun Melsungen AG; Baxter; BD; Caesarea Medical Electronics; Smiths Medical; Terumo Corporation; JMS Co. Ltd. |
| Customization & Pricing | Available upon Request |
The market is estimated to secure a valuation of US$ 2.3 billion in 2023.
The market’s is estimated to develop at a CAGR of 6.6%.
CVS/Coram and Option Care Health are the key market players.
The infusion system accessories segment is likely to remain preferred through 2033.
The global market size is estimated to reach US$ 4.4 billion by 2033.
1. Executive Summary | Home Infusion Therapy Devices Market 1.1. Global Market Outlook 1.2. Demand-side Trends 1.3. Supply-side Trends 1.4. Technology Roadmap Analysis 1.5. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 3. Market Background 3.1. Market Dynamics 3.1.1. Drivers 3.1.2. Restraints 3.1.3. Opportunity 3.1.4. Trends 3.2. Scenario Forecast 3.2.1. Demand in Optimistic Scenario 3.2.2. Demand in Likely Scenario 3.2.3. Demand in Conservative Scenario 3.3. Opportunity Map Analysis 3.4. Product Life Cycle Analysis 3.5. Supply Chain Analysis 3.5.1. Supply Side Participants and their Roles 3.5.1.1. Producers 3.5.1.2. Mid-Level Participants (Traders/ Agents/ Brokers) 3.5.1.3. Wholesalers and Distributors 3.5.2. Value Added and Value Created at Node in the Supply Chain 3.5.3. List of Raw Material Suppliers 3.5.4. List of Existing and Potential Buyers 3.6. Investment Feasibility Matrix 3.7. Value Chain Analysis 3.7.1. Profit Margin Analysis 3.7.2. Wholesalers and Distributors 3.7.3. Retailers 3.8. PESTLE and Porter’s Analysis 3.9. Regulatory Landscape 3.9.1. By Key Regions 3.9.2. By Key Countries 3.10. Regional Parent Market Outlook 3.11. Production and Consumption Statistics 3.12. Import and Export Statistics 4. Global Market Analysis 2017 to 2022 and Forecast, 2023 to 2033 4.1. Historical Market Size Value (US$ Million) & Volume (Units) Analysis, 2017 to 2022 4.2. Current and Future Market Size Value (US$ Million) & Volume (Units) Projections, 2023 to 2033 4.2.1. Y-o-Y Growth Trend Analysis 4.2.2. Absolute $ Opportunity Analysis 5. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Product Type 5.1. Introduction / Key Findings 5.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Product Type, 2017 to 2022 5.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Product Type, 2023 to 2033 5.3.1. Disposable Elastomeric Pumps 5.3.2. Insulin Pumps 5.3.3. PCA Pumps 5.3.4. Electronic Ambulatory Pumps 5.3.5. Infusion System Accessories 5.4. Y-o-Y Growth Trend Analysis By Product Type, 2017 to 2022 5.5. Absolute $ Opportunity Analysis By Product Type, 2023 to 2033 6. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Application 6.1. Introduction / Key Findings 6.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Application, 2017 to 2022 6.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Application, 2023 to 2033 6.3.1. Enteral Nutrition 6.3.2. Parenteral Nutrition 6.3.3. Chemotherapy 6.3.4. Antibiotic Administration 6.3.5. Others 6.4. Y-o-Y Growth Trend Analysis By Application, 2017 to 2022 6.5. Absolute $ Opportunity Analysis By Application, 2023 to 2033 7. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By End User 7.1. Introduction / Key Findings 7.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By End User, 2017 to 2022 7.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By End User, 2023 to 2033 7.3.1. Home Care Settings 7.3.2. Long Term Care Centers 7.4. Y-o-Y Growth Trend Analysis By End User, 2017 to 2022 7.5. Absolute $ Opportunity Analysis By End User, 2023 to 2033 8. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Region 8.1. Introduction 8.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Region, 2017 to 2022 8.3. Current Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Region, 2023 to 2033 8.3.1. North America 8.3.2. Latin America 8.3.3. Europe 8.3.4. East Asia 8.3.5. South Asia 8.3.6. Oceania 8.3.7. Middle East and Africa(MEA) 8.4. Market Attractiveness Analysis By Region 9. North America Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country 9.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2017 to 2022 9.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033 9.2.1. By Country 9.2.1.1. USA 9.2.1.2. Canada 9.2.2. By Product Type 9.2.3. By Application 9.2.4. By End User 9.3. Market Attractiveness Analysis 9.3.1. By Country 9.3.2. By Product Type 9.3.3. By Application 9.3.4. By End User 9.4. Key Takeaways 10. Latin America Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country 10.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2017 to 2022 10.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033 10.2.1. By Country 10.2.1.1. Brazil 10.2.1.2. Mexico 10.2.1.3. Rest of Latin America 10.2.2. By Product Type 10.2.3. By Application 10.2.4. By End User 10.3. Market Attractiveness Analysis 10.3.1. By Country 10.3.2. By Product Type 10.3.3. By Application 10.3.4. By End User 10.4. Key Takeaways 11. Europe Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country 11.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2017 to 2022 11.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033 11.2.1. By Country 11.2.1.1. Germany 11.2.1.2. Italy 11.2.1.3. France 11.2.1.4. United Kingdom 11.2.1.5. Spain 11.2.1.6. BENELUX 11.2.1.7. Russia 11.2.1.8. Rest of Europe 11.2.2. By Product Type 11.2.3. By Application 11.2.4. By End User 11.3. Market Attractiveness Analysis 11.3.1. By Country 11.3.2. By Product Type 11.3.3. By Application 11.3.4. By End User 11.4. Key Takeaways 12. East Asia Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country 12.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2017 to 2022 12.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033 12.2.1. By Country 12.2.1.1. China 12.2.1.2. Japan 12.2.1.3. South Korea 12.2.2. By Product Type 12.2.3. By Application 12.2.4. By End User 12.3. Market Attractiveness Analysis 12.3.1. By Country 12.3.2. By Product Type 12.3.3. By Application 12.3.4. By End User 12.4. Key Takeaways 13. South Asia Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country 13.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2017 to 2022 13.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033 13.2.1. By Country 13.2.1.1. India 13.2.1.2. Malaysia 13.2.1.3. Thailand 13.2.1.4. Indonesia 13.2.1.5. Rest of South Asia 13.2.2. By Product Type 13.2.3. By Application 13.2.4. By End User 13.3. Market Attractiveness Analysis 13.3.1. By Country 13.3.2. By Product Type 13.3.3. By Application 13.3.4. By End User 13.4. Key Takeaways 14. Oceania Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country 14.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2017 to 2022 14.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033 14.2.1. By Country 14.2.1.1. Australia 14.2.1.2. New Zealand 14.2.2. By Product Type 14.2.3. By Application 14.2.4. By End User 14.3. Market Attractiveness Analysis 14.3.1. By Country 14.3.2. By Product Type 14.3.3. By Application 14.3.4. By End User 14.4. Key Takeaways 15. MEA Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country 15.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2017 to 2022 15.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033 15.2.1. By Country 15.2.1.1. GCC Countries 15.2.1.2. Turkey 15.2.1.3. South Africa 15.2.1.4. Rest of Middle East and Africa(MEA) 15.2.2. By Product Type 15.2.3. By Application 15.2.4. By End User 15.3. Market Attractiveness Analysis 15.3.1. By Country 15.3.2. By Product Type 15.3.3. By Application 15.3.4. By End User 15.4. Key Takeaways 16. Key Countries Market Analysis 16.1. USA 16.1.1. Pricing Analysis 16.1.2. Market Share Analysis, 2022 16.1.2.1. By Product Type 16.1.2.2. By Application 16.1.2.3. By End User 16.2. Canada 16.2.1. Pricing Analysis 16.2.2. Market Share Analysis, 2022 16.2.2.1. By Product Type 16.2.2.2. By Application 16.2.2.3. By End User 16.3. Brazil 16.3.1. Pricing Analysis 16.3.2. Market Share Analysis, 2022 16.3.2.1. By Product Type 16.3.2.2. By Application 16.3.2.3. By End User 16.4. Mexico 16.4.1. Pricing Analysis 16.4.2. Market Share Analysis, 2022 16.4.2.1. By Product Type 16.4.2.2. By Application 16.4.2.3. By End User 16.5. Germany 16.5.1. Pricing Analysis 16.5.2. Market Share Analysis, 2022 16.5.2.1. By Product Type 16.5.2.2. By Application 16.5.2.3. By End User 16.6. France 16.6.1. Pricing Analysis 16.6.2. Market Share Analysis, 2022 16.6.2.1. By Product Type 16.6.2.2. By Application 16.6.2.3. By End User 16.7. United Kingdom 16.7.1. Pricing Analysis 16.7.2. Market Share Analysis, 2022 16.7.2.1. By Product Type 16.7.2.2. By Application 16.7.2.3. By End User 16.8. Italy 16.8.1. Pricing Analysis 16.8.2. Market Share Analysis, 2022 16.8.2.1. By Product Type 16.8.2.2. By Application 16.8.2.3. By End User 16.9. Spain 16.9.1. Pricing Analysis 16.9.2. Market Share Analysis, 2022 16.9.2.1. By Product Type 16.9.2.2. By Application 16.9.2.3. By End User 16.10. Russia 16.10.1. Pricing Analysis 16.10.2. Market Share Analysis, 2022 16.10.2.1. By Product Type 16.10.2.2. By Application 16.10.2.3. By End User 16.11. Poland 16.11.1. Pricing Analysis 16.11.2. Market Share Analysis, 2022 16.11.2.1. By Product Type 16.11.2.2. By Application 16.11.2.3. By End User 16.12. China 16.12.1. Pricing Analysis 16.12.2. Market Share Analysis, 2022 16.12.2.1. By Product Type 16.12.2.2. By Application 16.12.2.3. By End User 16.13. Japan 16.13.1. Pricing Analysis 16.13.2. Market Share Analysis, 2022 16.13.2.1. By Product Type 16.13.2.2. By Application 16.13.2.3. By End User 16.14. South Korea 16.14.1. Pricing Analysis 16.14.2. Market Share Analysis, 2022 16.14.2.1. By Product Type 16.14.2.2. By Application 16.14.2.3. By End User 16.15. India 16.15.1. Pricing Analysis 16.15.2. Market Share Analysis, 2022 16.15.2.1. By Product Type 16.15.2.2. By Application 16.15.2.3. By End User 16.16. Thailand 16.16.1. Pricing Analysis 16.16.2. Market Share Analysis, 2022 16.16.2.1. By Product Type 16.16.2.2. By Application 16.16.2.3. By End User 16.17. Malaysia 16.17.1. Pricing Analysis 16.17.2. Market Share Analysis, 2022 16.17.2.1. By Product Type 16.17.2.2. By Application 16.17.2.3. By End User 16.18. Australia 16.18.1. Pricing Analysis 16.18.2. Market Share Analysis, 2022 16.18.2.1. By Product Type 16.18.2.2. By Application 16.18.2.3. By End User 16.19. New Zealand 16.19.1. Pricing Analysis 16.19.2. Market Share Analysis, 2022 16.19.2.1. By Product Type 16.19.2.2. By Application 16.19.2.3. By End User 16.20. GCC Countries 16.20.1. Pricing Analysis 16.20.2. Market Share Analysis, 2022 16.20.2.1. By Product Type 16.20.2.2. By Application 16.20.2.3. By End User 16.21. Turkey 16.21.1. Pricing Analysis 16.21.2. Market Share Analysis, 2022 16.21.2.1. By Product Type 16.21.2.2. By Application 16.21.2.3. By End User 16.22. Northern Africa 16.22.1. Pricing Analysis 16.22.2. Market Share Analysis, 2022 16.22.2.1. By Product Type 16.22.2.2. By Application 16.22.2.3. By End User 16.23. South Africa 16.23.1. Pricing Analysis 16.23.2. Market Share Analysis, 2022 16.23.2.1. By Product Type 16.23.2.2. By Application 16.23.2.3. By End User 17. Market Structure Analysis 17.1. Competition Dashboard 17.2. Competition Benchmarking 17.3. Market Share Analysis of Top Players 17.3.1. By Regional 17.3.2. By Product Type 17.3.3. By Application 17.3.4. By End User 18. Competition Analysis 18.1. Competition Deep Dive 18.1.1. Baxter International Inc. 18.1.1.1. Overview 18.1.1.2. Product Portfolio 18.1.1.3. Profitability by Market Segments 18.1.1.4. Sales Footprint 18.1.1.5. Strategy Overview 18.1.1.5.1. Marketing Strategy 18.1.1.5.2. Product Strategy 18.1.1.5.3. Channel Strategy 18.1.2. Fresenius Kabi AG 18.1.2.1. Overview 18.1.2.2. Product Portfolio 18.1.2.3. Profitability by Market Segments 18.1.2.4. Sales Footprint 18.1.2.5. Strategy Overview 18.1.2.5.1. Marketing Strategy 18.1.2.5.2. Product Strategy 18.1.2.5.3. Channel Strategy 18.1.3. B. Braun Melsungen AG 18.1.3.1. Overview 18.1.3.2. Product Portfolio 18.1.3.3. Profitability by Market Segments 18.1.3.4. Sales Footprint 18.1.3.5. Strategy Overview 18.1.3.5.1. Marketing Strategy 18.1.3.5.2. Product Strategy 18.1.3.5.3. Channel Strategy 18.1.4. Becton, Dickinson, and Company 18.1.4.1. Overview 18.1.4.2. Product Portfolio 18.1.4.3. Profitability by Market Segments 18.1.4.4. Sales Footprint 18.1.4.5. Strategy Overview 18.1.4.5.1. Marketing Strategy 18.1.4.5.2. Product Strategy 18.1.4.5.3. Channel Strategy 18.1.5. Smith & Nephew PLC. 18.1.5.1. Overview 18.1.5.2. Product Portfolio 18.1.5.3. Profitability by Market Segments 18.1.5.4. Sales Footprint 18.1.5.5. Strategy Overview 18.1.5.5.1. Marketing Strategy 18.1.5.5.2. Product Strategy 18.1.5.5.3. Channel Strategy 18.1.6. Nipro Corporation 18.1.6.1. Overview 18.1.6.2. Product Portfolio 18.1.6.3. Profitability by Market Segments 18.1.6.4. Sales Footprint 18.1.6.5. Strategy Overview 18.1.6.5.1. Marketing Strategy 18.1.6.5.2. Product Strategy 18.1.6.5.3. Channel Strategy 18.1.7. Pfizer Inc. 18.1.7.1. Overview 18.1.7.2. Product Portfolio 18.1.7.3. Profitability by Market Segments 18.1.7.4. Sales Footprint 18.1.7.5. Strategy Overview 18.1.7.5.1. Marketing Strategy 18.1.7.5.2. Product Strategy 18.1.7.5.3. Channel Strategy 18.1.8. F. Hoffmann-La Roche Ltd 18.1.8.1. Overview 18.1.8.2. Product Portfolio 18.1.8.3. Profitability by Market Segments 18.1.8.4. Sales Footprint 18.1.8.5. Strategy Overview 18.1.8.5.1. Marketing Strategy 18.1.8.5.2. Product Strategy 18.1.8.5.3. Channel Strategy 18.1.9. Johnson & Johnson 18.1.9.1. Overview 18.1.9.2. Product Portfolio 18.1.9.3. Profitability by Market Segments 18.1.9.4. Sales Footprint 18.1.9.5. Strategy Overview 18.1.9.5.1. Marketing Strategy 18.1.9.5.2. Product Strategy 18.1.9.5.3. Channel Strategy 18.1.10. Terumo Corporation 18.1.10.1. Overview 18.1.10.2. Product Portfolio 18.1.10.3. Profitability by Market Segments 18.1.10.4. Sales Footprint 18.1.10.5. Strategy Overview 18.1.10.5.1. Marketing Strategy 18.1.10.5.2. Product Strategy 18.1.10.5.3. Channel Strategy 18.1.11. Micrel Medical Devices S.A. 18.1.11.1. Overview 18.1.11.2. Product Portfolio 18.1.11.3. Profitability by Market Segments 18.1.11.4. Sales Footprint 18.1.11.5. Strategy Overview 18.1.11.5.1. Marketing Strategy 18.1.11.5.2. Product Strategy 18.1.11.5.3. Channel Strategy 18.1.12. JMS Co. Ltd. 18.1.12.1. Overview 18.1.12.2. Product Portfolio 18.1.12.3. Profitability by Market Segments 18.1.12.4. Sales Footprint 18.1.12.5. Strategy Overview 18.1.12.5.1. Marketing Strategy 18.1.12.5.2. Product Strategy 18.1.12.5.3. Channel Strategy 19. Assumptions & Acronyms Used 20. Research Methodology
Explore Healthcare Insights
View Reports
Home Infusion Therapy Devices Market
